University Hospital
Welcome,         Profile    Billing    Logout  
 3 Trials 
11 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mraovic, Boris
NCT03824808: Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

Terminated
4
21
US
Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution, Lidocaine, 0.9% Sodium Chloride Injection, Normal Saline
University of Missouri-Columbia
Kidney Cancer, Prostate Cancer
03/20
03/20
NCT05887375: Sugammadex Vs Neostigmine/glycopyrrolate on Urinary Retention After Spine Surgery

Enrolling by invitation
4
118
US
Sugammadex, Bridion, MK-8616, Neostigmine, Bloxiverz, Glycopyrrolate, Glycopyrrolate injection, USP, Rocuronium, Rocuronium Bromide
University of Missouri-Columbia, Merck Sharp & Dohme LLC
Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative
07/25
09/25
NCT03876873: Effect of Head Rotation on Efficacy of Face Mask Ventilation in Anesthetized Obese (BMI ≥ 35) Adults

Completed
N/A
21
US
Head Rotation During Face Mask Ventilation, Medline Top Valve Anesthesia Mask, Face Mask
University of Missouri-Columbia
Noninvasive Ventilation
02/23
02/23
Ibdah, Jamal
NCT05526144: Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans

Recruiting
2
128
US
Synthroid, Levothyroxine, T4, Placebo
VA Office of Research and Development
Nonalcoholic Steatohepatitis, Liver Fibrosis
03/29
03/29
NCT03151798: The Liver Health Study for Patients with NAFLD

Completed
N/A
336
US
Phase II: Lifestyle treatment, Phase II: Control treatment, Phase I: Observational studies
University of Missouri-Columbia
Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Obesity
03/22
04/23
Murray, Katie
NCT03824808: Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

Terminated
4
21
US
Lidocaine Hydrochloride 0.8% in Dextrose 5% Solution, Lidocaine, 0.9% Sodium Chloride Injection, Normal Saline
University of Missouri-Columbia
Kidney Cancer, Prostate Cancer
03/20
03/20
TURBT, NCT06111235: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following

Recruiting
3
364
Canada, US
Cretostimogene Grenadenorepvec, CG0070, n-dodecyl-B-D-maltoside, DDM
CG Oncology, Inc.
Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer, Urothelial Carcinoma
01/28
01/30
NCT04122196: Perioperative Pregabalin in Ureteroscopy

Completed
2/3
118
US
Pregabalin 300mg, Lyrica, Placebo oral tablet
University of Missouri-Columbia
Kidney Stone, Pain, Postoperative, Addiction, Opioid Use
07/23
07/24
NCT05987241: Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment, MODERN Study

Recruiting
2/3
1190
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, cfDNA or ctDNA Measurement, Cell-Free DNA/Circulating Tumor DNA Measurement, cfDNA/ctdDNA Measurement, cfDNA/ctDNA, cfDNA/ctDNA Measurement, Circulating Cell-Free DNA/Circulating Tumor-Derived DNA Measurement, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Relatlimab, BMS 986016, BMS-986016, BMS986016, Immunoglobulin G4, Anti-(human Lymphocyte Activation Gene-3 Protein) (Human Heavy Chain), Disulfide with Human Light Chain, Dimer
National Cancer Institute (NCI)
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage IV Bladder Urothelial Carcinoma AJCC v7
04/26
04/26
A222001, NCT04600336: Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer

Completed
2
88
US
Oxybutynin Chloride, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Prostate Carcinoma
02/24
03/24
A031701, NCT03609216: Gemcitabine and Cisplatin Without Cystectomy for Patients with Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

Recruiting
2
271
US
Gemcitabine Hydrochloride, Cisplatin, Pegfilgrastim, Conventional Surgery, Radical Cystectomy, Chemoradiotherapy
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma, Stage III Bladder Urothelial Carcinoma
02/27
02/29

Download Options